Fabian Zohren - Jan 29, 2025 Form 4 Insider Report for Merus N.V. (MRUS)

Role
Chief Medical Officer
Signature
/s/ Peter B. Silverman, attorney-in-fact Fabian Zohren
Stock symbol
MRUS
Transactions as of
Jan 29, 2025
Transactions value $
$0
Form type
4
Date filed
1/31/2025, 04:30 PM
Previous filing
Jul 3, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRUS Share Option (right to buy) Award $0 +50K $0.00 50K Jan 29, 2025 Common Shares 50K $41.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest over a four-year period from January 1, 2025. 25% vest on January 1, 2026 and in 36 equal monthly installments thereafter.